Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 02/12 11:14:18 am
68.375 EUR   +1.64%
02/10 Sovereign funds' selling could hit $700 billion of European stock..
02/10DJSanofi's Diabetes Approach Stumbles
02/09DJSanofi Is Forced to End Latest Diabetes Effort
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 01:44am US/Eastern

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.

MAIN FACTS:

- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at inti.landauro@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : SANOFI
React to this article
Latest news on SANOFI
02/11 GENZYME : Trademark Application for "IMPATH" Filed by Genzyme Corporation
02/10 Sovereign funds' selling could hit $700 billion of European stocks
02/10DJSanofi's Diabetes Approach Stumbles
02/09DJSanofi Is Forced to End Latest Diabetes Effort
02/09 SANOFI : earnings to be 'stable' despite declining sales
02/09 SANOFI : Study Signifies Progress for Cardiovascular Disease Treatment and Perso..
02/09 SANOFI : and Positive Planet Partnership Promote Access to Care and Quality of H..
02/09 SANOFI : Delivered 2015 Business EPS up 8.5% on a Reported Basis and Stable at C..
02/09DJRegeneron Reports Slowing Sales Growth for Key Eye Drug
02/09 Sanofi pledges stable 2016 earnings
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials